1 / 10

United States Generic Drugs Market Forecast

Access full Research:<br><br>https://www.renub.com/united-states-off-label-drugs-market-and-forecast-51-p.php<br><br>United States Generic Drugs Market is projected to exceed USD 210 Billion by the year 2024. United States Generic Drugs Market is so huge that nearly 80% of dispensing prescriptions accounts generic drugs. According to FDA in the United States 9 out of 10 prescriptions filled are for generic drugs. Most of the physicians and hospitals are now prescribing generic drugs than that of the brand-name drugs. Generic Drugs are those drugs which have same active component as patent drugs in same outline & equal amounts. Generic drugs are also called as Off-Label drugs. <br><br>The prime reason for the growth of United States Generic Drugs Market can be attributed to its pricing, on an average generic (Off-Label) drug is around 40-60% cheaper than those of Branded Drugs. However, this price of generic drug further declines, when various generic drug companies target a single approved drug, then market competition results in prices 85% less than the branded drugs. Also, increasing number of drug patent expirations, government initiatives and rising prevalence of chronic diseases are some other factors which are expected to propel the growth of United States Generic Drugs Market in the near future.<br> <br>Request a free sample copy of the report: <br>https://www.renub.com/contactus.php<br> <br>Renub Research report titled “United States Generic Drugs Market, By Therapeutic Application [Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU)/Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others], Companies (Teva, Mylan N.V., Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma, & Others)” provides a complete analysis of US Generic Drugs Market. <br> <br>Therapeutic Application – Oncology Generic Drug Market is likely to witness a Significant Growth during the Forecast Period<br>The report studies the market of the following Therapeutic Application segments: Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU) / Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others. Central Nervous System (CNS), Cardiovascular, Respiratory and Oncology are some of the segments that will attract the attention of generic drugs market participants.<br>All companies in this report has been covered with following view points<br>1. Company Strategy<br>2. Sales<br><br>Companies Analysis<br>Teva, Mylan, Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma are some of the top companies operating in the United States Generic Drug Market; which has been studied thoroughly in the report. <br>

renubresearch
Download Presentation

United States Generic Drugs Market Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category: Drugs & Pharmaceuticals Market Report

  2. United States Generic off Label Drugs Market Analyst View: • United States Generic Drugs Market to be USD 210 Billion by 2024. GetFree Customization in this Report • Research Report Title: • United States Generic Drugs Market, By Therapeutic Application [Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU)/Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others], Companies (Teva, Mylan N.V., Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma, & Others) • Access Full Research:  • https://www.renub.com/united-states-off-label-drugs-market-and-forecast-51-p.php

  3. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. United States Generic Drugs Market is projected to exceed USD 210 Billion by the year 2024. United States Generic Drugs Market is so huge that nearly 80% of dispensing prescriptions accounts generic drugs. According to FDA in the United States 9 out of 10 prescriptions filled are for generic drugs. Most of the physicians and hospitals are now prescribing generic drugs than that of the brand-name drugs. Generic Drugs are those drugs which have same active component as patent drugs in same outline & equal amounts. Generic drugs are also called as Off-Label drugs.  The prime reason for the growth of United States Generic Drugs Market can be attributed to its pricing, on an average generic (Off-Label) drug is around 40-60% cheaper than those of Branded Drugs. However, this price of generic drug further declines, when various generic drug companies target a single approved drug, then market competition results in prices 85% less than the branded drugs. Also, increasing number of drug patent expirations, government initiatives and rising prevalence of chronic diseases are some other factors which are expected to propel the growth of United States Generic Drugs Market in the near future.

  4. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. Request a free sample copy of the report:https://www.renub.com/contactus.php Renub Research report titled “United States Generic Drugs Market, By Therapeutic Application [Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU)/Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others], Companies (Teva, Mylan N.V., Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma, & Others)” provides a complete analysis of US Generic Drugs Market.  Therapeutic Application – Oncology Generic Drug Market is likely to witness a Significant Growth during the Forecast Period The report studies the market of the following Therapeutic Application segments: Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU) / Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others. Central Nervous System (CNS), Cardiovascular, Respiratory and Oncology are some of the segments that will attract the attention of generic drugs market participants. All companies in this report has been covered with following view points 1.    Company Strategy2.    Sales

  5. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024.

  6. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. Companies Analysis Teva, Mylan, Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma are some of the top companies operating in the United States Generic Drug Market; which has been studied thoroughly in the report. Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/united-states-off-label-drugs-market-and-forecast-51-p.php By Therapeutic Application: •    Central Nervous System (CNS) •    Cardiovascular•    Dermatology •    Anti-infective •    Genitourinary (GU)/Harmonal Drugs •    Respiratory•    Oncology •    OthersKey Companies Covered in the Report: •    Teva •    Mylan N.V. •    Sandoz •    Lupin Limited •    Dr Reddy’s •    Endo Pharmaceuticals•    Sun Pharma •    Others

  7. Table of Contents for United States Generic Drugs Market Key Topics Covered 1. Executive Summary 2. United States Pharmaceutical Market 2.1 Branded Pharmaceutical Market 2.2 Generics Pharmaceutical Market 3. United States Generic Drugs Saving 4. Market Share – United States Pharmaceutical 4.1 Branded vs. Generics Drugs 4.2 Branded Generic vs. Unbranded Generic Drug 4.3 Volume Penetration – Generic vs. Branded Drugs 4.4 Therapeutic Application 5. United States Generic Drugs Market (2010 – 2024) 5.1 Branded Generic Drugs Market 5.2 Unbranded Generic Drugs Market

  8. Table of Contents for United States Generic Drugs Market 6. Therapeutic Application – United States Generic Drugs Market (2010 – 2024) 6.1 Central Nervous System (CNS) 6.2 Cardiovascular 6.3 Dermatology 6.4 Genitourinary / Hormonal Drugs 6.5 Respiratory 6.6 Anti-infective 6.7 Oncology 6.8 Others 7. Teva Pharmaceutical Industries Ltd - Company Analysis 7.1 Product Launch 7.2 Financial Insight 8. Mylan N.V. - Company Analysis 8.1 Product Launch 8.2 Financial Insight 9. Sandoz Inc. - Company Analysis 9.1 Product Launch 9.2 Financial Insight 10. Endo Pharmaceuticals - Company Analysis 10.1 Product Launch 10.2 Financial Insight

  9. Table of Contents for United States Generic Drugs Market 11. Lupin Limited - Company Analysis 11.1 Product Launch 11.2 Financial Insight 12. Dr Reddy's - Company Analysis 12.1 Business Portfolio 12.2 Financial Insight 13. Sun Pharmaceutical Industries Ltd. - Company Analysis 13.1 Product Launch 13.2 Financial Insight 14. Others 14.1 Financial Insight 15. Growth Driver 15.1 Rising Geriatric Population of United States 15.2 Generic Drugs Cost less than Brand Name Drugs 15.3 Rising Incidence of non-communicable Diseases 16. Challenges 16.1 Lack of Regulation & Information 16.2 Long Halt for Expiration of Patent Drug

  10. GetFree Customization in this Report • Drugs & Pharmaceuticals Market Reports: • https://www.renub.com/drugs-and-pharmaceuticals-13-c.php

More Related